High-Purity Cannabinol Composition for Sleep Disorder Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for sleep disturbances, such as insomnia and jet lag, often come with drawbacks like rebound insomnia, delayed sedative effects, side effects like psychomotor and memory deficits, and the risk of habit formation, and there is a lack of research on the sleep aid effects of cannabinol (CBN).
Innovation Solution
Administering a composition containing high-purity cannabinol, either alone or in combination with low amounts of cannabidiol and Δ9(10)-THC, in specific dosages to reduce sleep disturbances and treat sleep disorders, with the cannabinol having a purity of at least 90% to minimize side effects and maximize sedative effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current sedatives and hypnotics are used to treat sleep disturbances, then sleep onset and maintenance are improved, but side effects such as psychomotor deficits, memory deficits, myorelaxation, and disturbed sleep architecture occur
Solution Approach 1:
The patent extracts and isolates cannabinol (CBN) as a specific active ingredient from the complex mixture of cannabinoids, focusing on its unique sedative properties while excluding other compounds that may cause harmful side effects. This extraction approach allows for targeted therapeutic action with reduced adverse effects.
Solution Approach 2:
The patent specifies precise dosage parameters for CBN (2.5mg to 100mg per serving) and controls the concentration of other cannabinoids (THC ≤ 0.5wt%, CBD ≤ 0.5wt%) to optimize therapeutic effects while minimizing side effects. This parameter control resolves the contradiction by finding the optimal dosage range.
2Reliability
If sedatives and hypnotics are used to treat sleep disturbances, then sleep induction is improved, but rebound insomnia and habit formation occur
Solution Approach 1:
The patent positions CBN as a non-habit forming, non-addictive alternative to traditional sedatives that work on a single-use basis without creating dependence. The composition is designed for occasional use to treat sleep disturbances without risking long-term dependence, effectively treating the 'dependence risk' as a disposable concern rather than a chronic issue.
3Reliability
If melatonin supplements are used to treat sleep disorders, then sleep phase regulation is improved, but dependence and side effects such as headache, dizziness, and daytime drowsiness occur
Solution Approach 1:
The patent merges CBN with low doses of other cannabinoids (THC and CBD) to create a synergistic composition that enhances sleep phase regulation while counteracting the side effects of individual components. CBD specifically counteracts the daytime drowsiness and other adverse effects associated with melatonin and THC.
4Reliability
If high purity cannabinol is administered to maximize sedative effects, then sleep quality is improved, but the risk of psychoactive effects from THC contamination increases
Solution Approach 1:
The patent establishes specific parameter thresholds: CBN purity of at least 90%, THC content ≤ 0.5wt%, and CBD content ≤ 0.5wt%. These parameter changes ensure that the sedative effects of high-purity CBN are maximized while the psychoactive effects of THC are kept below perceptible levels.
Solution Approach 2:
The patent uses CBD as an intermediary substance that modulates the psychoactive effects of THC. By including controlled amounts of CBD (≤ 0.5wt%), the composition reduces the psychoactive impact of THC contamination while maintaining the sedative benefits of CBN.
Data Source
AI summary
Provided are compositions containing cannabinol, or a pharmaceutically acceptable salt thereof, and methods of reducing sleep disturbances in a subject, comprising administering the cannabinol composition to the subject. Also provided are methods of treating sleep disorders in a subject, comprising administering the cannabinol composition to the subject.